- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT02094781
Effect of Using Whey Protein and Creatine Supplements on Muscular Strength in Weight-training Adult Males
December 11, 2014 updated by: GlaxoSmithKline
A Randomized, Double-blind, Placebo-controlled, Three-arm Trial to Evaluate the Effect of Using Whey Protein and Creatine Supplements on Muscular Strength in Weight-training Adult Males
The purpose of this study was to evaluate the effect of combined whey protein and creatine supplement, as compared with whey protein supplement alone, on change in upper and lower body strength.
Study Overview
Status
Completed
Conditions
Study Type
Interventional
Enrollment (Actual)
18
Phase
- Phase 1
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
Florida
-
Miami, Florida, United States, 33143
- GSK Investigational Site
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
14 years to 31 years (Adult)
Accepts Healthy Volunteers
No
Genders Eligible for Study
Male
Description
Inclusion Criteria:
- Recreationally active males
- Age 18 to 35 years
- BMI 19 to 29.9 kg/m2
- Weight training 3 to 4 times a week for at least 6 months before the trial
Exclusion Criteria:
- Participants with medical conditions including active heart disease, high blood pressure, renal or hepatic impairment type I or II diabetes, bipolar disease, pulmonary disease, thyroid disease, immune disorder, psychiatric disorder
- Dietary or herbal supplement used in the past 60 days to increase muscle mass
- Use of protein supplement in the past 7 days
- Use of thermogenic supplement or beverage in the past 7 days
- Use of Non-steroidal anti inflammatory drugs or corticosteroids in the past 7 days
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: Basic Science
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: Triple
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Experimental: Whey protein and creatine supplement
Each sachet contained 30g whey protein powder and 5g creatine powder, administered twice a day.
The first serving was consumed with breakfast and the second serving was consumed within 60 minutes of completing training or in the evening on non-training days.
Participants also drank at least 2 litres of water per day
|
Each sachet contained 30g whey protein powder and 5g creatine powder, administered twice a day.
The first serving was consumed with breakfast and the second serving was consumed within 60 minutes of completing training or in the evening on non-training days.
Participants also drank at least 2 litres of water per day
|
|
Active Comparator: Whey protein only supplement
Each sachet contained 30g of whey protein powder and 5g of bulking agent powder, administered twice a day.
The first serving was consumed with breakfast and the second serving was consumed within 60 minutes of completing training or in the evening on non-training days.
Participants also drank at least 2 litres of water per day
|
Each sachet contained 30g of whey protein powder and 5g of bulking agent powder, administered twice a day.
The first serving was consumed with breakfast and the second serving was consumed within 60 minutes of completing training or in the evening on non-training days.
Participants also drank at least 2 litres of water per day
|
|
Placebo Comparator: Placebo
Each sachet contained 30g of isocaloric carbohydrate powder and 5g of bulking agent powder, administered twice a day.
The first serving was consumed with breakfast and the second serving was consumed within 60 minutes of completing training or in the evening on non-training days.
Participants also drank at least 2 litres of water per day
|
Each sachet contained 30g of isocaloric carbohydrate powder and 5g of bulking agent powder, administered twice a day.
The first serving was consumed with breakfast and the second serving was consumed within 60 minutes of completing training or in the evening on non-training days.
Participants also drank at least 2 litres of water per day
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
To evaluate the effect of combined whey protein and creatine supplement, as compared with whey protein supplement alone, on change in upper body strength from Baseline to Week 4.
Time Frame: Baseline, Week 2, 4, 8 and 12
|
Body strength will be evaluated using Repetition maximum (1-RM) and bench and leg press exercise testing.
1-RM in weight training is the maximum amount of weight one can lift in a single repetition for a given exercise
|
Baseline, Week 2, 4, 8 and 12
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
To evaluate the effect of combined whey protein and creatine supplement, as compared with whey protein supplement alone, on changes in upper and lower body strength from Baseline through Week 12
Time Frame: Baseline, Week 2, 4, 8 and 12
|
Body strength will be evaluated using 1-RM and bench and leg press exercise testing
|
Baseline, Week 2, 4, 8 and 12
|
|
To evaluate the effect of combined whey protein and creatine supplement, as compared with placebo, on changes in upper and lower body strength from Baseline through Week 12.
Time Frame: Baseline, Week 2, 4, 8 and 12
|
Body strength will be evaluated using 1-RM and bench and leg press exercise testing
|
Baseline, Week 2, 4, 8 and 12
|
|
To compare changes in upper and lower body strength from Baseline through Week 12, between combined whey protein and creatine supplement, whey protein supplement alone, and placebo.
Time Frame: Baseline, Week 2, 4, 8 and 12
|
Body strength will be evaluated using 1-RM and bench and leg press exercise testing
|
Baseline, Week 2, 4, 8 and 12
|
|
To compare changes in upper and lower body endurance from Baseline through Week 12, between combined whey protein and creatine supplement, whey protein supplement alone, and placebo.
Time Frame: Baseline, Week 2, 4, 8 and 12
|
Body endurance will be measured using bench press and leg press exercise testing
|
Baseline, Week 2, 4, 8 and 12
|
|
To compare the changes in lean vs. fat body mass composition from Baseline to Week 12 between combined whey protein and creatine supplement, whey protein supplement alone, and placebo.
Time Frame: Baseline and Week 12
|
Body composition [(fat-free mass and fat mass (grams and % body fat, bone mass)] will be calculated using Dual X-Ray Absorptiometry (DXA)
|
Baseline and Week 12
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start
December 1, 2013
Primary Completion (Actual)
September 1, 2014
Study Completion (Actual)
September 1, 2014
Study Registration Dates
First Submitted
February 27, 2014
First Submitted That Met QC Criteria
March 20, 2014
First Posted (Estimate)
March 24, 2014
Study Record Updates
Last Update Posted (Estimate)
December 15, 2014
Last Update Submitted That Met QC Criteria
December 11, 2014
Last Verified
December 1, 2014
More Information
Terms related to this study
Other Study ID Numbers
- 200616
- RH01717 (Other Identifier: GSK)
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Nutritional Status
-
Second Affiliated Hospital, School of Medicine,...Zhejiang University; Sir Run Run Shaw Hospital; Red Cross Hospital, Hangzhou,... and other collaboratorsCompleted
-
GlaxoSmithKlineCompleted
-
International Centre for Diarrhoeal Disease Research...United States Agency for International Development (USAID)Not yet recruiting
-
China Medical University HospitalUnknown
-
GlaxoSmithKlineCompleted
-
Centre Hospitalier Universitaire DijonCompleted
-
Hillel Yaffe Medical CenterUnknownNutritional StatusIsrael
-
Bandim Health ProjectCompleted
-
University of CopenhagenUniversity of Aberdeen; University of Stirling; Noakhali Science and Technology... and other collaboratorsNot yet recruitingNutritional Status | Climate Change | Micronutrient Status | Omega 3 Fat Status | Fish Consumption | Dietary Pattern | Female AutonomyBangladesh
-
North-West University, South AfricaMedical Research Council, South Africa; National Research Foundation of South... and other collaboratorsCompletedMalnutrition | Vitamin A Status | Iron Status | Zinc StatusSouth Africa
Clinical Trials on Whey protein and creatine supplement
-
University of ReginaIovate Health Sciences International IncRecruiting
-
University of Sao PauloCompleted
-
Daniel MooreLesaffre InternationalRecruiting
-
Syracuse UniversityDairy Research InstituteCompletedBlood PressureUnited States
-
Sports Performance and Applied Research in Trials...RecruitingRecovery | Muscle Strength | Sports Nutritional Sciences | Supplements | Muscle Strength RecoveryUnited Kingdom
-
University of KansasDairy Management Inc.Completed
-
University College DublinFHI 360Active, not recruitingAging | Undernutrition | Appetite LossIreland
-
McMaster UniversityCompletedSkeletal Muscle HypertrophyCanada
-
University of GreenwichCompleted
-
Loughborough UniversityVolac International LimitedRecruitingAgeing Well | Neuromuscular FunctionUnited Kingdom